Compounds > ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate
Page last updated: 2024-08-23

ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Cerebro-Hepato-Renal Syndrome

ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate has been researched along with Cerebro-Hepato-Renal Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, T; Imanaka, T; Iwashima, M; Kanai, M; Mizuno, S; Morita, M; Shimozawa, N; Suzuki, Y1
Dhaunsi, GS; Lazo, O; Ozand, P; Pahan, K; Singh, I1
Hashimoto, T; Orii, T; Shimozawa, N; Suzuki, Y; Yajima, S; Yamaguchi, S1

Other Studies

3 other study(ies) available for ethyl 2-(5-(4-chlorophenyl)pentyl)oxiran-2-carboxylate and Cerebro-Hepato-Renal Syndrome

ArticleYear
Baicalein 5,6,7-trimethyl ether activates peroxisomal but not mitochondrial fatty acid beta-oxidation.
    Journal of inherited metabolic disease, 2008, Volume: 31, Issue:3

    Topics: Adrenoleukodystrophy; ATP Binding Cassette Transporter, Subfamily D; ATP-Binding Cassette Transporters; Carnitine Acyltransferases; Cells, Cultured; Coenzyme A Ligases; Epoxy Compounds; Fatty Acids; Fibroblasts; Flavanones; Glioblastoma; Humans; Mitochondria; Oxidation-Reduction; Peroxisomes; Zellweger Syndrome

2008
Phytanic acid alpha-oxidation. Differential subcellular localization in rat and human tissues and its inhibition by nycodenz.
    The Journal of biological chemistry, 1993, May-15, Volume: 268, Issue:14

    Topics: Adrenoleukodystrophy; Animals; Cell Fractionation; Cells, Cultured; Centrifugation, Density Gradient; Chlorides; Chondrodysplasia Punctata; Epoxy Compounds; Fatty Acids; Ferric Compounds; Fibroblasts; Humans; Hypoglycemic Agents; Iohexol; Kinetics; Liver; Microbodies; Mitochondria; Organelles; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Phytanic Acid; Rats; Rats, Sprague-Dawley; Skin; Subcellular Fractions; Zellweger Syndrome

1993
Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on fatty acid oxidation in fibroblasts from patients with peroxisomal diseases.
    Biochemical pharmacology, 1991, Feb-01, Volume: 41, Issue:3

    Topics: Adrenoleukodystrophy; Cells, Cultured; Epoxy Compounds; Fatty Acids; Humans; Infant; Infant, Newborn; Microbodies; Oxidation-Reduction; Palmitates; Zellweger Syndrome

1991